ALMSAlumis Inc.
$7.17+72% 1Y
$7.17
$3.9552 weeks$30.07
Is the price fair?
What ALMS's price assumes
Alumis Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 432× revenue.
432
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 7.07
Price / book · as of 2026-Q2
Details›
- Price / bookas of 2026-Q2
- 7.07
- EV / EBIToperating margin −6204%: the multiple describes the denominator
- not meaningful
- Market capitalisation
- $3.19B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Biotechnology
The closest names by size in the same industry